Nine Chapters Capital Management’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-37,900
Closed -$850K 1006
2015
Q1
$850K Buy
37,900
+8,200
+28% +$157K 0.07% 419
2014
Q4
$501K Buy
+29,700
New +$452K 0.04% 537
2014
Q3
Sell
-5,890
Closed -$94K 1031
2014
Q2
$94K Buy
5,890
+250
+4% +$3.77K 0.01% 880
2014
Q1
$102K Sell
5,640
-6,600
-54% -$122K 0.01% 761
2013
Q4
$240K Buy
12,240
+5,970
+95% +$87.4K 0.02% 674
2013
Q3
$75K Buy
6,270
+3,560
+131% +$44.8K 0.01% 704
2013
Q2
$30K Buy
+2,710
New +$57.1K 0.01% 609

Other funds holding DVAX

Nine Chapters Capital Management's DVAX Position: Q2 2015 in Review

Nine Chapters Capital Management sold out of Dynavax Technologies (DVAX) in Q2 2015, closing a stake of 37,900 shares — an estimated $850K sold.

Nine Chapters Capital Management first reported a position in DVAX in Q2 2013 and held it in 7 quarters. The position peaked at $850K in Q1 2015. 120 funds tracked by Wall St. Rank hold DVAX as of Q2 2015.

  • Nine Chapters Capital Management reported no remaining Dynavax Technologies position as of Q2 2015 after selling out during the quarter.
  • Nine Chapters Capital Management sold 37,900 Dynavax Technologies shares in Q2 2015, an estimated $850K.
  • Nine Chapters Capital Management first reported a position in Dynavax Technologies in Q2 2013 and held it in 7 quarters.
  • Nine Chapters Capital Management's Dynavax Technologies position peaked at $850K in Q1 2015.
  • 120 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2015.

Based on Nine Chapters Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.